Number of Shares
62,000.00
Current Holdings Value*
$806,620.00
% of Portfolio
5.15%
Total Estimate Gain
$219,090.00
% of Total Estimate Gain
36.67%

Lion Point Capital, LP's Benitec Biopharma Inc Holding Summary

As of 2025-03-31, Lion Point Capital, LP held 62,000.00 shares of Benitec Biopharma Inc(BNTC), totaling $806,620.00. This investment constitutes 5.15% of their stock portfolio, and Lion Point Capital, LP now holds 0.24% of the outstanding Benitec Biopharma Inc(BNTC) stock.

The initial trade took place in 2024Q3. And since then Lion Point Capital, LP has made 2 purchases of BNTC, at an average price of $9.64, for a total of 62,000.00 shares. Based on historical transaction data and BNTC's current price of $13.17, Lion Point Capital, LP's estimated gain on his BNTC holdings is $219,090.00, reflecting a 36.67% gain to date.

Lion Point Capital, LP BNTC ($13.17) Holding Chart

Lion Point Capital, LP BNTC ($13.17) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1